Construction of Enzyme Nanoreactors to Enable Tumor Microenvironment Modulation and Enhanced Cancer Treatment

Xiaowen Liu1, Yu Hao2, Rachela Popovtzer3

  • 1Clinical Translational Center for Targeted Drug, Department of Pharmacology, School of Medicine, Jinan University, Guangzhou, Guangdong Province, 510632, China.

Insights

Enzyme nanoreactors can suppress tumor growth and enhance cancer treatments by modifying the tumor microenvironment (TME). This review covers their construction and application in reducing hypoxia and oxidative stress.

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Cancer Therapy

Background:

  • Enzymes are crucial for biological functions and disease treatment.
  • The tumor microenvironment (TME) often hinders cancer therapy effectiveness.
  • Enzymes show potential in directly suppressing tumors and improving treatment outcomes by modulating the TME.

Purpose of the Study:

  • To review chemical approaches for creating enzyme nanoreactors with retained catalytic activity and reduced immunogenicity.
  • To discuss the application of these nanoreactors in modulating the TME.
  • To provide perspectives on future developments for enhanced cancer treatment.

Main Methods:

  • Summary of chemical synthesis strategies for enzyme nanoreactors.
  • Discussion of nanoreactor applications in altering TME characteristics.
  • Exploration of TME modulation for cancer therapy.

Main Results:

  • Enzyme nanoreactors can be chemically constructed with preserved function and lower immunogenicity.
  • These nanoreactors effectively attenuate tumor hypoxia and modulate the extracellular matrix.
  • Applications include amplifying tumor oxidative stress for therapeutic benefit.

Conclusions:

  • Enzyme nanoreactors offer a promising strategy for TME modulation in cancer treatment.
  • Further development of these nanoreactors could significantly enhance therapeutic efficacy.
  • Targeting the TME with enzyme nanoreactors represents a novel approach in oncology.